ÂÜÀòÂÒÂ×

Yen Chen Huang began their career in 2013 as Regional Chief Executive at SynCore Biotechnology Co., Ltd., where they were responsible for the business development in ASEAN countries. In 2014, they joined Diamond BioFund Inc. as Vice President and later became Assistant Vice President, where they were responsible for direct investing on Biotech/Healthcare/Medical device industries. In 2015, they became a Board Director at 3D Global Biotech Inc., a biotech company focus on developing three-dimensional bioprinting technology. In 2016, they joined IOPtima Ltd. as a Board Director and Theia Medical Technology Co., Ltd. as a Director Board Of Directors. In 2017, they became a Board Director at EyeYon Medical, a start-up company specializing in developing medical ophthalmic devices. In 2019, they joined Sinew pharma as a Director Board Of Directors and Swissray International as a Board Director. Finally, in 2020, they became a Director Board Of Directors at StemCyte Cord Blood Bank.

Yen Chen Huang has a history of education spanning from 1999 to 2014. In 1999, they earned a Bachelor of Science (BSc) in Biological Science with Business Administration from National Sun Yat-Sen University. Yen Chen then pursued a Master of Science (MSc) in Biophysics & Biosensors from National Yang Ming University from 2003 to 2005. In 2005, they earned a Program in Biotechnology Management and Innovation from National Chengchi University in the field of Biotechnology Management. Finally, from 2013 to 2014, they earned an M.S., MIT Global Scale network- MISI in Supply Chain Management from the Massachusetts Institute of Technology.